Is ALLK or RYLD a better dividend investment in 2026?

ALLK currently yields 607.72% with a 5% 5-year dividend growth rate. RYLD yields 12.14% with 5% growth. The better choice depends on your goal: ALLK offers higher current income.

What is the dividend yield difference between ALLK and RYLD?

ALLK has a forward dividend yield of 607.72% ($2.00/share annually). RYLD yields 12.14% ($1.81/share annually). The yield gap is 595.58 percentage points.

Home › Compare › ALLK vs RYLD

ALLK vs RYLD: Dividend Comparison 2026

ALLK yields 607.72% · RYLD yields 12.14%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 ALLK wins by $286605.31M in total portfolio value

INVESTMENT

TIME HORIZON10 years

ALLK

● Live price

607.72%

Share price

$0.33

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$286605.35M

Annual income

$216,519,218,488.39

Full ALLK calculator →

RYLD

● Live price

12.14%

Share price

$14.95

Annual div

$1.81

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$44.5K

Annual income

$2,587.35

Full RYLD calculator →

Portfolio growth — ALLK vs RYLD

📍 ALLK pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	ALLK	RYLD
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, ALLK + RYLD cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

ALLK pays

RYLD pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ALLK

Annual income on $10K today (after 15% tax)

$51,656.03/yr

After 10yr DRIP, annual income (after tax)

$184,041,335,715.13/yr

RYLD

Annual income on $10K today (after 15% tax)

$1,031.60/yr

After 10yr DRIP, annual income (after tax)

$2,199.25/yr

At 15% tax rate, ALLK beats the other by $184,041,333,515.88/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ALLK + RYLD for your $10,000?

ALLK: 50%RYLD: 50%

100% RYLD50/50100% ALLK

Portfolio after 10yr

$143302.70M

Annual income

$108,259,610,537.86/yr

Blended yield

75.55%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on ALLK right now

ALLK

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$109.50

+33172.6% upside vs current

Range: $1.00 — $218.00

Altman Z

-29.6

Piotroski

1/9

RYLD

No analyst data

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ALLK buys

RYLD buys

Politician	Chamber	Ticker	Type	Amount	Date
Chris Jacobs	🏢 House	$ALLK	▲ Buy	$1,001 - $15,000	2022-06-16

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricALLKRYLD

Forward yield	607.72% ✓	12.14%
Annual dividend / share	$2.00 ✓	$1.81
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$286605.35M ✓	$44.5K
Annual income after 10y	$216,519,218,488.39 ✓	$2,587.35
Total dividends collected	$280771.00M ✓	$18.8K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: ALLK vs RYLD ($10,000, DRIP)

Year	ALLK Portfolio	ALLK Income/yr	RYLD Portfolio	RYLD Income/yr	Gap
1← crossover	$71,472	$60,771.80	$11,914	$1,213.65	+$59.6K → ALLK
2	$482,407	$405,931.79	$14,099	$1,351.30	+$468.3K → ALLK
3	$3,076,811	$2,560,635.83	$16,580	$1,494.55	+$3.06M → ALLK
4	$18,555,598	$15,263,410.61	$19,384	$1,642.61	+$18.54M → ALLK
5	$105,882,914	$86,028,423.50	$22,535	$1,794.70	+$105.86M → ALLK
6	$572,079,610	$458,784,892.67	$26,063	$1,950.00	+$572.05M → ALLK
7	$2,928,751,131	$2,316,625,947.86	$29,995	$2,107.69	+$2928.72M → ALLK
8	$14,217,805,100	$11,084,041,390.41	$34,361	$2,266.99	+$14217.77M → ALLK
9	$65,501,061,274	$50,288,009,817.01	$39,194	$2,427.12	+$65501.02M → ALLK
10	$286,605,354,052	$216,519,218,488.39	$44,525	$2,587.35	+$286605.31M → ALLK

ALLK vs RYLD: Complete Analysis 2026

ALLK — Stock

Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and/or eosinophilic duodenitis; a Phase II/III study for eosinophilic esophagitis; and a Phase II clinical study to atopic dermatitis and chronic spontaneous urticaria. It is also developing lirentelimab (AK002) for the treatment of mast cell gastrointestinal disease, chronic urticaria, severe allergic conjunctivitis, and indolent systemic mastocytosis; and AK006 to treat allergic and inflammatory diseases. The company was incorporated in 2012 and is headquartered in Redwood City, California.

Full ALLK Calculator →

RYLD — ETF

The Global X Russell 2000 Covered Call ETF (RYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe Russell 2000 BuyWrite Index.

Full RYLD Calculator →

📬

Get this ALLK vs RYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ALLK vs SCHD ALLK vs JEPI ALLK vs O ALLK vs KO ALLK vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.